Murata Keiko | Department Of Clinical Trial Design And Management Translational Research Center Graduate School Of
スポンサーリンク
概要
- MURATA Keikoの詳細を見る
- 同名の論文著者
- Department Of Clinical Trial Design And Management Translational Research Center Graduate School Of の論文著者
Department Of Clinical Trial Design And Management Translational Research Center Graduate School Of | 論文
- UGT1A1^*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- Phase I/II Clinical Trial : Transplantation of Autologous Endothelial Progenitor Cells in Patients with Chronic Critical Limb Ischemia(Angiogenesis 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- 6 Therapeutic Angiogenesis for Patients with Chronic Limb Ischemia by Autologous Transplantation of Bone Marrow Mononuclear Cells : 3-Year Results of the TACT Trial, Long Term Prognosis, Efficacy and Safety(Late Breaking Clinical Trials I,Special Program,
- 4 Concurrent Vasculogenesis and Cardiomyogenesis by Somatic Stem/Progenitor Cell Transplantation for Functional Regenerative Recovery Post Myocardial Infarction(Cell Death and Repair-Regeneration in Cardiac and Vascular Diseases,Plenary Session 3 (PL3) (M
- OE-326 Transplantation of Endothelial Progenitor Cells is Safe and Effective for Therapeutic Neovascularization in No-Option Patients with Chronic Critical Limb Ischemia(Regeneration (angionenesis/myocardial regeneration)-2 (M) OE55,Oral Presentation (Eng